Quantcast

Latest radiation therapy Stories

2014-04-09 11:41:42

Results from the study could help determine potential treatment options A quartet of proteins that play critical roles in cell replication, cell death, and DNA repair could lead to better targets for therapy against treatment-resistant head-and-neck squamous cell cancers. In a study to be presented at the AACR Annual Meeting 2014 on Tuesday, April 8, Ranee Mehra, MD, a medical oncologist who specializes in head and neck cancers at Fox Chase Cancer Center, and colleagues, showed a...

2014-04-07 16:35:29

Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue. Dr Trine Grantzau (MD) told the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna: "We found that for each Gray delivered to the lung as part of radiotherapy for a breast tumour, the relative risk of...

2014-04-07 16:10:23

A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive. Now, researchers at the Stanford University School of Medicine have devised a way to quickly bring...

2014-04-07 15:55:09

For the first time, researchers have been able to demonstrate that the use of helium ions in radiation therapy could provide accurate treatment to tumors while helping to spare healthy organs. A treatment planning study to be presented at the ESTRO 33 congress today [Sunday] has been able to show that helium may have effects that are superior to radiotherapy using protons, themselves a considerable advance on conventional photon beam radiotherapy. Mr Hermann Fuchs, a PhD student at the...

2014-04-07 12:47:39

A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). Professor Robert Bristow will tell the conference that although surgery and precision radiotherapy are the mainstays of treatment for cancer that is confined to the prostate, the cancer...

2014-04-07 12:45:16

The use of permanent brachytherapy, a procedure where radioactive sources are placed inside the prostate, into or near to the tumor, preserves erectile function in approximately 50% of patients with prostate cancer, a researcher will tell the ESTRO 33 congress today (Saturday). Brachytherapy works by giving a high dose of radiotherapy directly to the tumor, but only a very low dose to the surrounding normal tissues. Since erectile dysfunction (ED) can occur in up to 68% of patients who...

2014-04-07 12:33:09

Next-generation CyberKnife 10.0 Increases Accuracy, Reduces Treatment Time WESTERVILLE, Ohio, April 7, 2014 /PRNewswire/ -- Columbus CyberKnife, a service of Mount Carmel St. Ann's Hospital, recently completed a major upgrade of its cancer treatment technology to the next-generation CyberKnife(®) 10.0 system. http://photos.prnewswire.com/prnvar/20140407/DA98217 CyberKnife is a robotic technology that performs stereotactic body radiation therapy (SBRT), a nonsurgical method of...

2014-04-07 08:31:28

Where experience and state-of-the-art technology meet SUNNYVALE, Calif., April 7, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the European CyberKnife Center Munich-Grosshadern (ECZM) has performed 5,000 CyberKnife® treatments since June 2005. The center uses a CyberKnife M6(TM) System from the latest generation series, the most advanced robotic radiosurgery system in the world. Patients of the center benefit from a treatment option that offers...

2014-04-07 08:31:25

HOUSTON, April 7, 2014 /PRNewswire/ -- C4 Imaging LLC is pleased to announce the first patient implant with Sirius(TM), its novel positive-signal MRI Marker. Sirius(TM) is used following treatment of prostate cancer with brachytherapy to facilitate seed localization within the prostate, utilizing a single post-implant Magnetic Resonance (MR) imaging procedure. The first implant was performed at The University of Texas MD Anderson Cancer Center (Houston, Texas) and was used during a procedure...

2014-04-07 08:30:25

Presentation "DNA Damage Response and Tumor Metastasis" to be Presented April 7, 2014 at ESTRO 33, the Premier European Event in Radiation Oncology BIRMINGHAM, Ala., April 7, 2014 /PRNewswire/ -- Southern Research Institute today announced that the Institute's translational radiation oncology research program in the Drug Discovery Division has been invited to present at a symposium during the European Society of Radiotherapy and Oncology (ESTRO) 33(rd) annual meeting being held in...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related